Tirzepatide 10mg Vial

Tirzepatide is a dual incretin receptor agonist that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) pathways. It is used clinically to improve glycaemic control and support weight management by enhancing insulin secretion, reducing appetite, and slowing gastric emptying. Tirzepatide influences metabolic regulation through these complementary mechanisms, leading to improved glucose utilisation and reduced caloric intake. In research settings, it is studied for its effects on metabolic health and obesity-related pathways. It is typically administered via subcutaneous injection, with dosing adjusted according to response and protocol.